Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Type 2 diabetes is characterized by insulin resistance with a relative deficiency in insulin secretion. This study explored the potential communication between insulin-resistant human skeletal muscle and primary (human and rat) β-cells. RESEARCH DESIGN AND METHODS: Human skeletal muscle cells were cultured for up to 24 h with tumor necrosis factor (TNF)-α to induce insulin resistance, and mRNA expression for cytokines was analyzed and compared with controls (without TNF-α). Conditioned media were collected and candidate cytokines were measured by antibody array. Human and rat primary β-cells were used to explore the impact of exposure to conditioned media for 24 h on apoptosis, proliferation, short-term insulin secretion, and key signaling protein phosphorylation and expression. RESULTS: Human myotubes express and release a different panel of myokines depending on their insulin sensitivity, with each panel exerting differential effects on β-cells. Conditioned medium from control myotubes increased proliferation and glucose-stimulated insulin secretion (GSIS) from primary β-cells, whereas conditioned medium from TNF-α–treated insulin-resistant myotubes (TMs) exerted detrimental effects that were either independent (increased apoptosis and decreased proliferation) or dependent on the presence of TNF-α in TM (blunted GSIS). Knockdown of β-cell mitogen-activated protein 4 kinase 4 prevented these effects. Glucagon-like peptide 1 protected β-cells against decreased proliferation and apoptosis evoked by TMs, while interleukin-1 receptor antagonist only prevented the latter. CONCLUSIONS: Taken together, these data suggest a possible new route of communication between skeletal muscle and β-cells that is modulated by insulin resistance and could contribute to normal β-cell functional mass in healthy subjects, as well as the decrease seen in type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“TNFα secretion from T2D subjects was higher than healthy controls,207,208 and one in vitro study has shown that this myokine impairs beta-cell function.208”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [208]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“TNFα secretion from T2D subjects was higher than healthy controls,207,208 and one in vitro study has shown that this myokine impairs beta-cell function.208”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maedler, K., Schumann, D. M., Sauter, N., Ellingsgaard, H., Bosco, D., Baertschiger, R., Iwakura, Y., Oberholzer, J., Wollheim, C. B., Gauthier, B. R., et al. (2006) · Diabetes · doi:10.2337/db05-1430 · Cited by 156
Self-citationRetractedMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“To understand the mechanism involved in type 2 diabetes development, peripheral insulin resistance and b-cell function have to be studied in parallel (36,37).”
BackgroundC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · cited 1×
“Low-grade systemic inflammation is also a feature of obesity and diabetes (38), raising the hypothesis that elevated cytokine levels may contribute to insulin resistance and decreased b-cell functional mass (39).”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“IRS-1 and -2 have been shown to be central in both insulin production and secretion (27,28).”
BackgroundMasters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 1×
“2 and 3), which has been shown to be involved in type 2 diabetes (30,31).”
BackgroundGenetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265 · cited 1×
“Type 1 (insulindependent) diabetes thus results from autoimmune destruction of pancreatic b-cells (1), and it is now recognized that there is decreased b-cell mass and function in type 2 diabetes (2) but the precise underlying mechanism remains to be determined.”
BackgroundIncreased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citationPlomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627 · cited 2×
“We showed previously that TNF-a can induce insulin resistance in human skeletal muscle by altering the insulin signaling pathway (16), providing a unique system for molecular dissection in vitro (17).”
BackgroundSelf-citationGlucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Self-citation
Cited by
Items 101–121 of 121
Levy, Y. A., Ciaraldi, T. P., Mudaliar, S. R. D., Phillips, S. A., & Henry, R. R. (2022) · Adipocyte · doi:10.1080/21623945.2022.2070949 · Cited by 4
“amount of GROα secreted from OAT appears to much less than that produced by myotubes [14,15,36,37].”
BackgroundPrepregnancy Fat Free Mass and Associations to Glucose Metabolism Before and During Pregnancy
Diaz, E. C., Børsheim, E., Shankar, K., Cleves, M. A., & Andres, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01381 · Cited by 4
Pedersen, B. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_31 · Cited by 7
Self-citationSambashivaiah, S., Bhadra, R., Bhattacharya, S., & Kurpad, A. V. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-022-00349-2 · Cited by 3
Levy, Y. A., Ciaraldi, T. P., & Henry, R. R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06104-z · Cited by 4
Fabp4, a new player in the adipo-pancreatic axis
Ye, R., & Scherer, P. E. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.03.009 · Cited by 2
TAS1R3 Regulates GTPase Signaling in Human Skeletal Muscle Cells for Glucose Uptake
Hoolachan, J. M., Balakrishnan, R., Merz, K. E., Thurmond, D. C., & Veluthakal, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010103 · Cited by 2
Danowska, M., Nikołajuk, A., & Strączkowski, M. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02781-4 · Cited by 2
To the issue of neuro-immuno-endocrine system theory
Valeriy, C., & Yushkov, B. G. (2026) · Russian Journal of Immunology · doi:10.46235/1028-7221-17074-tti · Cited by 3
“IL-6 оказывает влияние на функцию поджелудочной железы, стимулируя пролифера-цию и глюкозоопосредованную секрецию инсу-лина секрецию инсулина β -клетками [60, 92].”
Pedersen, B. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_31-1 · Cited by 1
Self-citationInsulinorésistance : communication cellule musculaire-pancréas endocrine
Bouzakri, K., Plomgaard, P., & Berney, T. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70252-8
Self-citationThe role of MAP4K4 in cardiac muscle cell death
Jenkins, M. (2018) · Spiral (Imperial College London) · doi:10.25560/62638
How to Treat or Prevent, or Slow Down, Cellular Ageing and Senescence?
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_7
Recarey-Rodríguez, A. E. (2021) · Academica-e (Universidad Pública de Navarra) · doi:10.48035/tesis/2454/39685 · Cited by 1
Treatment Regimes in Diabetes and Their Impact on Biomarkers: Exercise, Inflammation, and Lipids
Magalhães, J. P., Hetherington‐Rauth, M., & Sardinha, L. B. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_3-1
Treatment Regimes in Diabetes and Their Impact on Biomarkers: Exercise, Inflammation, and Lipids
Magalhães, J. P., Hetherington‐Rauth, M., & Sardinha, L. B. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_3
Muskulatur: „peripheres mechanisch- und Signalstoff-gestütztes Zentrum der Gesundheit“
Laube, W. (2023) · Springer eBooks · doi:10.1007/978-3-662-67753-7_8
Role of Myokines and prospects for their role in Diabetes Mellitus Therapy
Nuriya, K., Farida, M., Sharma, R., Liliya, S., Mkhitaryan, X. E., Chergizova, B., Salikhova, Y., Niyazova, Y., Ryspayeva, G., Evnevich, A., et al. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00786
Parenté, A. (2019) · theses.fr (ABES) · doi:10.70675/3d9a23f5z3546z46f1z957cz5d167994539d
Metadata
- Authors
- Bouzakri, K., Plomgaard, P., Berney, T., Donath, M. Y., Pedersen, B. K., & Halban, P. A.
- Affiliations
- University of Geneva (CH)
- University of Copenhagen (DK)
- University Hospital of Geneva (CH)
- University Hospital of Basel (CH)
- Department of Infectious Diseases and the Copenhagen Muscle Research Centre, The Centre of Inflammation and Metabolism, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
- Corresponding author
- Bouzakri, Karim
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-03-22
- Volume
- 60
- Issue
- 4
- Pages
- 1111-1121
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3064085
- OpenAlex
- W2170623101
- Cited by
- 122
- References
- 47
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 8 · 2017: 12 · 2016: 10 · 2015: 9 · 2014: 12 · 2013: 10 · 2012: 5
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-01-01)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- HAL (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Strategiske Forskningsråd (09-067009 and 09-075724, 09–067009, 09 – 075724)
- Sundhed og Sygdom, Det Frie Forskningsråd
- National Research Foundation
- Danmarks Grundforskningsfond (# 02-512-55, 09-067009, 09-075724)
- Ministério da Ciência, Tecnologia e Inovação
- Region Hovedstaden
- Université de Genève
- Diabetesforeningen
- Medical Research Council
- Center for Strategic Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- pancreatic beta cells, skeletal muscle, insulin resistance, type 2 diabetes, myokines, TNF-α, glucose-stimulated insulin secretion, beta-cell apoptosis, beta-cell proliferation, MAPK4, glucagon-like peptide-1, interleukin-1 receptor antagonist, cytokines
- MeSH terms
- Insulin Secretion, Animals, Cells, Cultured, Humans, Insulin, Insulin Resistance, Male, Tumor Necrosis Factor-alpha, Cytokines, Culture Media, Conditioned, Rats, Wistar, Apoptosis, Protein Serine-Threonine Kinases, Muscle Fibers, Skeletal, In Situ Nick-End Labeling, RNA Interference, Cell Proliferation, Insulin-Secreting Cells, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.